In plain English
Tempus AI Inc. builds AI‑driven tools that help doctors diagnose and treat cancer, combining big data with clinical diagnostics. The…
Company stock · NASDAQ · USD
TEM
Tempus AI Inc
—
Price unavailable — company details still show below
- Sector
- Healthcare
- Industry
- Life Sciences Tools & Services
- Size
- Medium-sized company
- Market value
- $12.3 billion
- Number of shares
- 180.4 million
- Country
- US
- Went public
- May 30, 2025
- Exchange
- NASDAQ
- Website
- investors.tempus.com
Price chart Pro
Loading chart…
Loading chart…
Company briefing
What TEM is
Plain English context — why the name shows up in the news, and what to watch next.
Latest on this name
Insights & deeper context
3 recent cards — open any for the full deeper dive.
Tempus AI Doubles Down On Moderna and Merck Cancer Vaccine Infrastructure
In brief
Tempus is deepening ties with Moderna and Merck on a personalized cancer vaccine, but the deal’s financial upside remains unclear, weighing on its stock price today.
What’s Going On With Tempus AI Stock on Monday?
In brief
TEM’s recent pullback reflects a re‑pricing of its momentum‑driven rally, with FDA clearance adding a new product but analyst sentiment remaining split.
Why Is Tempus AI Stock Gaining Thursday?
In brief
Positive melanoma trial results are lifting Tempus AI shares as investors weigh the strategic value of its planned Personalis acquisition.
Company reports
Official filings (US SEC and linked cards)
No filings here yet
Official report cards for TEM will show up here when available.
Broad market indexes (like the S&P 500, a basket of 500 large US companies) are shown through popular funds that track them (for example SPY). Company profile and prices use live market data when available.